Company / Revenue per Share
Quest Diagnostics Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$97.65
FY2025
5-year range
$56.81 / $97.65
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
#21 of 153
Health Care
What the data says
Quest Diagnostics's revenue per share of $97.65 is higher than 86% of companies in the Health Care sector (FY2025). Revenue per Share has fluctuated over the past 10 years, ranging from $50.80 in FY2018 to $97.65 in FY2025.
Based on SEC 10-K filings.
97.65 in FY2025 with a 5-year CAGR of +7.5%. Top quartile in the Health Care sector.
Improved from $84.28 to $97.65 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +12.1%
- 5-Year CAGR
- +7.5%
- 10-Year CAGR
- -
Sector benchmark
-21.2% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 16.7% year-over-year.
- Ranks #21 out of 153 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $97.65 | +16.7% |
| FY2024 | $83.66 | -0.7% |
| FY2023 | $84.28 | +21.5% |
| FY2022 | $69.39 | +22.1% |
| FY2021 | $56.81 | -16.3% |
| FY2020 | $67.89 | +28.4% |
| FY2019 | $52.87 | +4.1% |
| FY2018 | $50.80 | -1.7% |
| FY2017 | $51.68 | +0.8% |
| FY2016 | $51.28 | +9.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026